logo
ProjectForthcoming

Artificial intelligence-based personalized and interactive radiotherapy target definition for enhanced cancer care

Forthcoming · Germany

Source: EU Funding & Tenders Portal

Cancer is the second leading cause of death globally, with radiotherapy (RT) being a cornerstone treatment for nearly half of all patients. A key element of RT is the accurate definition of target volumes, a task traditionally performed manually by physicians. The quality of target volumes differs significantly between treatment centers and healthcare systems, directly impacting patients’ outcomes

Status
Prospective
Sector
Bridge
Location
Germany
Updated
19 Nov 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Artificial intelligence-based personalized and interactive radiotherapy target definition for enhanced cancer care

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

3 Q
The project “Artificial intelligence-based personalized and interactive radiotherapy target definition for enhanced cancer care” is an infrastructure initiative in the Bridge sector, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Not available for this record.

Status

Original status

forthcoming

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Cancer is the second leading cause of death globally, with radiotherapy (RT) being a cornerstone treatment for nearly half of all patients. A key element of RT is the accurate definition of target volumes, a task traditionally performed manually by physicians. The quality of target volumes differs significantly between treatment centers and healthcare systems, directly impacting patients’ outcomes. While advances in artificial intelligence (AI) have simplified and standardized the segmentation of healthy organs, creating personalized target volumes that incorporate individual patient-specific data remains an unsolved challenge. AI-PIONEER aims to revolutionize the RT treatment planning process by combining the vast potential of multimodal large language models with 3D image segmentation. For the first time, AI-PIONEER will provide a language-based interface for target volume definition, offering a dynamic and adaptable solution for treatment planning. This will enable the unprecedented opportunity to process both scientific publications and patient-specific data to generate literature-founded, personalized, and precise target volumes. The project has three main objectives: (1) curating an extensive and high-quality multicenter CT dataset, (2) developing and fine-tuning a multimodal foundation AI model for personalized target volume creation, and (3) clinically validating the framework across multiple centers using prospective clinical data, ensuring robust results in real-world settings. By integrating cutting-edge AI technology with clinical expertise, AI-PIONEER will bridge the gaps between efficiency, standardization, and personalization in cancer treatment, ultimately improving patient outcomes worldwide. Thorough clinical validation will provide the basis for clinical translation. This approach is poised to significantly reduce the burden on clinicians while elevating the quality of cancer care.

Location

Country

Germany

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Bridge

Article published date

2025-11-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project